Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
Allogene Therapeutics, Inc. (ALLO)
Roberts Zachary — EVP of R&D
Shares
35,700
Price
$1.77
Total Value
$63.19K
Shares Held After
581,166
% of Holdings
5.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
5,843
Price
$42.08
Total Value
$245.90K
Shares Held After
30,167
% of Holdings
16.2%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
102,581
Price
$42.08
Total Value
$4.32M
Shares Held After
292,415
% of Holdings
26.0%
Allogene Therapeutics, Inc. (ALLO)
Yoshiyama Annie — SVP, Finance
Shares
4,167
Price
$1.72
Total Value
$7.17K
Shares Held After
130,322
% of Holdings
3.1%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
22,900
Price
$1.76
Total Value
$40.30K
Shares Held After
564,948
% of Holdings
3.9%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
6,615
Price
$20.54
Total Value
$135.87K
Shares Held After
167,617
% of Holdings
3.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
3,025
Price
$20.57
Total Value
$62.22K
Shares Held After
167,617
% of Holdings
1.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,472
Price
$20.57
Total Value
$30.28K
Shares Held After
167,617
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
15,500
Price
$14.69
Total Value
$227.62K
Shares Held After
3,363,898
% of Holdings
0.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
3,448
Price
$14.65
Total Value
$50.52K
Shares Held After
144,693
% of Holdings
2.3%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
15,500
Price
$14.68
Total Value
$227.59K
Shares Held After
3,363,965
% of Holdings
0.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
3,557
Price
$14.65
Total Value
$52.10K
Shares Held After
173,547
% of Holdings
2.0%
REVVITY, INC. (RVTY)
Vohra Tajinder S — Senior Vice President, Global Operations
Shares
5,756
Price
$104.50
Total Value
$601.50K
Shares Held After
10,442
% of Holdings
35.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
100
Price
$58.00
Total Value
$5.80K
Shares Held After
450,944
% of Holdings
0.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
16,463
Price
$83.03
Total Value
$1.37M
Shares Held After
80,293
% of Holdings
17.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
48,626
Price
$83.03
Total Value
$4.04M
Shares Held After
80,293
% of Holdings
37.7%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
20,000
Price
$82.60
Total Value
$1.65M
Shares Held After
80,293
% of Holdings
19.9%
Fulcrum Therapeutics, Inc. (FULC)
Gould Robert J — Director
Shares
15,000
Price
$10.72
Total Value
$160.86K
Shares Held After
454,864
% of Holdings
3.2%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
83,689
Price
$1.39
Total Value
$116.33K
Shares Held After
3,297,794
% of Holdings
2.5%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
114,891
Price
$1.39
Total Value
$159.70K
Shares Held After
3,206,233
% of Holdings
3.5%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
96,065
Price
$1.39
Total Value
$133.53K
Shares Held After
3,321,124
% of Holdings
2.8%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
46,660
Price
$1.39
Total Value
$64.86K
Shares Held After
3,417,189
% of Holdings
1.3%
Doximity, Inc. (DOCS)
Wampler Kira Scherer — Director
Shares
2,000
Price
$37.33
Total Value
$74.66K
Shares Held After
19,839
% of Holdings
9.2%
Akebia Therapeutics, Inc. (AKBA)
Ostrowski Erik — SVP, CFO, CBO & Treasurer
Shares
34,951
Price
$1.39
Total Value
$48.58K
Shares Held After
672,635
% of Holdings
4.9%
Akebia Therapeutics, Inc. (AKBA)
Rucci Carolyn M. — SVP, Chief Legal Officer
Shares
27,544
Price
$1.39
Total Value
$38.29K
Shares Held After
588,378
% of Holdings
4.5%
Akebia Therapeutics, Inc. (AKBA)
Rucci Carolyn M. — SVP, Chief Legal Officer
Shares
25,382
Price
$1.39
Total Value
$35.28K
Shares Held After
615,922
% of Holdings
4.0%
Akebia Therapeutics, Inc. (AKBA)
Rucci Carolyn M. — SVP, Chief Legal Officer
Shares
16,846
Price
$1.39
Total Value
$23.42K
Shares Held After
641,304
% of Holdings
2.6%
Akebia Therapeutics, Inc. (AKBA)
Burke Steven Keith — SVP, Chief Medical Officer
Shares
20,701
Price
$1.39
Total Value
$28.77K
Shares Held After
948,432
% of Holdings
2.1%
Akebia Therapeutics, Inc. (AKBA)
Burke Steven Keith — SVP, Chief Medical Officer
Shares
25,375
Price
$1.39
Total Value
$35.27K
Shares Held After
969,133
% of Holdings
2.6%
Akebia Therapeutics, Inc. (AKBA)
Burke Steven Keith — SVP, Chief Medical Officer
Shares
21,582
Price
$1.39
Total Value
$30.00K
Shares Held After
994,508
% of Holdings
2.1%
Akebia Therapeutics, Inc. (AKBA)
Grund Nicholas — Chief Commercial Officer
Shares
31,244
Price
$1.39
Total Value
$43.43K
Shares Held After
561,750
% of Holdings
5.3%
Akebia Therapeutics, Inc. (AKBA)
Grund Nicholas — Chief Commercial Officer
Shares
53,585
Price
$1.39
Total Value
$74.48K
Shares Held After
592,994
% of Holdings
8.3%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
100
Price
$156.86
Total Value
$15.69K
Shares Held After
84,907
% of Holdings
0.1%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
3,042
Price
$155.46
Total Value
$472.91K
Shares Held After
85,007
% of Holdings
3.5%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
3,349
Price
$154.56
Total Value
$517.62K
Shares Held After
88,049
% of Holdings
3.7%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
928
Price
$153.16
Total Value
$142.13K
Shares Held After
91,398
% of Holdings
1.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
563
Price
$152.06
Total Value
$85.61K
Shares Held After
92,326
% of Holdings
0.6%
Akebia Therapeutics, Inc. (AKBA)
Malabre Richard C — SVP, Chief Accounting Officer
Shares
13,382
Price
$1.39
Total Value
$18.60K
Shares Held After
299,390
% of Holdings
4.3%
Akebia Therapeutics, Inc. (AKBA)
Malabre Richard C — SVP, Chief Accounting Officer
Shares
36,142
Price
$1.39
Total Value
$50.24K
Shares Held After
312,772
% of Holdings
10.4%
ALX ONCOLOGY HOLDINGS INC (ALXO)
GOODMAN COREY S — Director
Shares
3,184,713
Price
$1.57
Total Value
$5.00M
Shares Held After
8,453,038
% of Holdings
37.7%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
968
Price
$103.30
Total Value
$100.00K
Shares Held After
4,503
% of Holdings
17.7%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
9,108
Price
$103.30
Total Value
$940.89K
Shares Held After
160,294
% of Holdings
5.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
2,631
Price
$103.30
Total Value
$271.79K
Shares Held After
20,655
% of Holdings
11.3%
RAPID MICRO BIOSYSTEMS, INC. (RPID)
Longitude Capital Partners II, LLC — 10% Owner
Shares
27,500
Price
$4.25
Total Value
$116.77K
Shares Held After
76,500
% of Holdings
26.4%
908 Devices Inc. (MASS)
Griffith Joseph H. IV — Chief Financial Officer
Shares
23,175
Price
$6.18
Total Value
$143.22K
Shares Held After
139,896
% of Holdings
14.2%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
34,764
Price
$6.18
Total Value
$214.84K
Shares Held After
795,968
% of Holdings
4.2%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
365
Price
$21.38
Total Value
$7.80K
Shares Held After
639,505
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
366
Price
$21.38
Total Value
$7.83K
Shares Held After
639,507
% of Holdings
0.1%
Centessa Pharmaceuticals plc (CNTA)
HUSSAIN IQBAL J — Chief Legal Officer
Shares
38,951
Price
$25.15
Total Value
$979.66K
Shares Held After
57,645
% of Holdings
40.3%
Pacira BioSciences, Inc. (PCRX)
RIKER LAUREN — Senior Vice President, Finance
Shares
4,000
Price
$20.81
Total Value
$83.24K
Shares Held After
52,313
% of Holdings
7.1%
Showing 1501–1550 of 1586 transactions (page 31 of 32)